Endoluxe Announces Return Of Founder Neal Patel, MD As CEO

ATLANTA–(BUSINESS WIRE)–Endoluxe, Inc. announced today the return of founder Neal Patel, MD as CEO of the company following the departure of former CEO Devon Bream. Devon left the company to join GE Healthcare as President/General Manager, Invasive Cardiology Image Guided Therapies. Endoluxe thanked Devon for his tenure as CEO and for the significant growth he brought to the company since 2021. Devon will continue to serve as a business advisor during this transition period. Dr. Patel will take over the reins from his current role as Chief Technology Officer (CTO) of both Endoluxe and his clinical practice Advanced Urology of Georgia.

Having founded Endoluxe in 2014 with Dr. Phil Zhao, Dr. Patel says, “I am incredibly excited to return to my role as CEO of Endoluxe. The company is positioned for strong growth and expansion into single-use disposable endoscopes and AI-augmented visualization for current clinical needs. We will build upon the many partnerships we have created in the past several years and make the Endoluxe Visualization System the camera of choice for endoscopic surgeons in the US and around the world.”

Dr. Patel and team will present at the Emerging Medtech Summit – Life Science Intelligence 2023 conference at Dana Point, CA in late March 2023. Endoluxe will meet with several venture capital firms to discuss additional fundraising, and with industry leaders to collaborate further partnerships. We will also be present and active at the American Urological Association annual meeting in Chicago in late April 2023. Endoluxe continues to work closely with Dornier MedTech as its distribution partner for the Endoluxe Visualization System.

About Endoluxe

Endoluxe is a world-class endoscopic video imaging organization based in the United States, with worldwide distribution of its medical industry design award-winning Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor-agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices while taking advantage of future technological advancements using our portable, integrated and feature-laden platform at 1/4th the cost of legacy products. More information can be found at www.endoluxe.com.